Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
暂无分享,去创建一个
[1] G. Navis,et al. Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. , 2011, Thrombosis research.
[2] O. Phung,et al. Statin use and the prevention of venous thromboembolism: a meta‐analysis , 2010, International journal of clinical practice.
[3] Carol Coupland,et al. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database , 2010, BMJ : British Medical Journal.
[4] W. Ageno,et al. Statins, fibrates, and venous thromboembolism: a meta-analysis. , 2010, European heart journal.
[5] A. Adler,et al. Micronutrients and diabetic retinopathy a systematic review. , 2010, Ophthalmology.
[6] A. Folsom,et al. C-reactive protein and venous thromboembolism , 2009, Thrombosis and Haemostasis.
[7] E. Fliers,et al. Hypercoagulable state in Cushing's syndrome: a systematic review. , 2009, The Journal of clinical endocrinology and metabolism.
[8] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.
[9] Markus Horneber,et al. Green tea (Camellia sinensis) for the prevention of cancer. , 2009, The Cochrane database of systematic reviews.
[10] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[11] P. Libby,et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. , 2009, The New England journal of medicine.
[12] F. Rosendaal,et al. HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.
[13] E. Horváth-Puhó,et al. Arterial cardiovascular events, statins, low‐dose aspirin and subsequent risk of venous thromboembolism: a population‐based case‐control study , 2009, Journal of thrombosis and haemostasis : JTH.
[14] G. Rutherford,et al. The role of breast-feeding in the prevention of Helicobacter pylori infection: a systematic review. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] P. Ridker,et al. An Evaluation of Candidate Genes of Inflammation and Thrombosis in Relation to the Risk of Venous Thromboembolism: The Women's Genome Health Study , 2009, Circulation. Cardiovascular genetics.
[16] P. Wille-Jørgensen,et al. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer – a systematic review , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[17] R. Hubbard,et al. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. , 2009, British journal of clinical pharmacology.
[18] G. Marks,et al. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. , 2008, JAMA.
[19] E. Oger,et al. Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia? , 2008, Thrombosis research.
[20] J. Cabane,et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. , 2007, The Journal of rheumatology.
[21] I. Olkin,et al. The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.
[22] T. Jefferson,et al. Influenza vaccination for healthcare workers who work with the elderly. , 2006, The Cochrane database of systematic reviews.
[23] S. Kahn,et al. The relationship between inflammation and venous thrombosis , 2005, Thrombosis and Haemostasis.
[24] Gordon H Guyatt,et al. Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system , 2005, BMC health services research.
[25] I. Pabinger,et al. Inflammation in patients with lupus anticoagulant and implications for thrombosis. , 2005, The Journal of rheumatology.
[26] E. Oger,et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital‐based case–control study , 2004, Fundamental & clinical pharmacology.
[27] J. Ray. Why might statins prevent venous thromboembolism: what needs to be done to know more? , 2002, Expert opinion on investigational drugs.
[28] E. Vittinghoff,et al. Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS) , 2002, Circulation.
[29] H. Jick,et al. Statins and the risk of idiopathic venous thromboembolism. , 2002, British journal of clinical pharmacology.
[30] A. Laupacis,et al. Use of statins and the subsequent development of deep vein thrombosis. , 2001, Archives of internal medicine.
[31] Jonathan A C Sterne,et al. Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.
[32] G H Guyatt,et al. A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.
[33] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .